Diagnostic Exosome Biomarkers Market

Comprehensive Analysis of the Diagnostic Exosome Biomarkers Market by Reagents, Kits, Serum/Plasma Kits, Urine Kits, and Software

A Paradigm Shift in Healthcare- Diagnostic Exosome Biomarkers Market Gains Momentum. Analyzing the Market Shifts and Emerging Opportunities in Industry

Request Sample

Diagnostic Exosome Biomarkers Market Outlook (2023 to 2033)

The global diagnostic exosome biomarkers market is anticipated to reach US$ 196.8 million by 2023. Diagnostic exosome biomarkers sales are anticipated to expand at a significant CAGR of 16.3% between 2023 and 2033. By 2033, the diagnostic exosome biomarkers market is expected to be worth US$ 888.5 million.

The market growth can be attributed to the increasing prevalence of cancer, ongoing research on exosomes, and the rising number of clinical studies and trials in exosome-based research expected to spur the diagnostic exosome biomarkers market during the forecast period. Even though there is no FDA-approved clinical exosome product, the number of clinical trials using exosome-based medicines and diagnostics continues to rise.

As of June 2021, ClinicalTrials.gov lists about 63 research trials using exosomes to treat disorders, a significant number associated with cancer development.
As per the International Agency for Research on Cancer’s GLOBOCAN 2020, there were about 19.3 million new cases of cancer and about 10 million cancer deaths in 2020.
It is anticipated that more than 1.8 million new cancer cases can be diagnosed in the United States in 2020, and over 0.6 million people to die due to the disease.

There has been a rise in studies focusing on comprehending the functionality of exosomes in diseases, especially cancer. Exosomes are associated with several cancer hallmarks that affect tumor spread, immunological regulation, and therapeutic hallmarks.

Diagnostic Exosome Biomarkers Industry (From 2018 to 2022)
CAGR	14.5%
Market Size - 2018	US$ 100.07 million
Market Size - 2022	US$ 172.1 million

Diagnostic Exosome Biomarkers Industry (From 2023 to 2033)
CAGR	16.3%
Market Size – 2023	US$ 196.8 million
Market Size - 2033	US$ 888.5 million

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Beyond Growth: Assessing Diagnostic Exosome Biomarkers Markets from 2018 to 2022 to the Booming Era of From 2023 to 2033

From 2018 to 2022, the diagnostic exosome biomarkers business experienced substantial growth as research and development in exosome-based diagnostics surged.

Advances in technology and an increased understanding of exosomes' role in disease pathology led to identifying potential biomarkers for various conditions, including cancer, neurodegenerative disorders, and infectious diseases. As a result, the diagnostic exosome biomarkers industry witnessed rising investments, product launches, and collaborations between biotech companies and research institutions.

The diagnostic exosome biomarkers market is expected to enter a booming era from 2023 to 2033. With the validation of exosome biomarkers and their adoption in clinical settings, exosome-based tests are likely to become routine diagnostic tools.

The shift toward personalized and non-invasive diagnostics may boost market growth for diagnostic exosome biomarkers, as these tests offer early detection and monitoring capabilities. The expanding applications of exosome-based therapeutics are anticipated to fuel market expansion for diagnostic exosome biomarkers.

Challenges such as standardization, regulatory hurdles, and cost considerations must be addressed to ensure the sustainable growth of the diagnostic exosome biomarkers market in the coming decade.

What Factors Contribute to The Growth of the Global Diagnostic Exosome Biomarkers Market?

Growing Investments in the Pharmaceutical Sector to Augment the Market Size

Most biopharmaceutical, pharmaceutical, and medical equipment manufacturers invest hugely in developing novel drugs and devices. Pharmaceutical companies make heavy research and development investments to produce high-quality and innovative products.

As per the EvaluatePharma report, pharmaceutical research and development expenditure was valued at US$ 136 billion in 2012, which increased to US$ 186 billion in 2019.

The introduction of new technologies is likely to benefit the diagnostic exosome biomarkers industry notably. Exotic devices, a new exosome isolation technology, were introduced recently and expanded significantly over time due to their various benefits, such as purity, high yield, and efficiency. The market is expected to flourish in the forecast period due to such factors.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Factors Hindering the Global Diagnostic Exosome Biomarkers Market?

Lack of Awareness and Strict Rules for Product Approval Hamper the Market

Lack of awareness and stringent rules for product approval are expected to hamper the market growth during the forecast period despite various developments in the market. Other factors hampering the market include a lack of unique biomarkers, inefficient separation techniques, and a need for high-resolution visualization equipment limiting understanding of exosomes.

The growing collaboration among diagnostic exosome biomarkers manufacturers is likely to counter the hampering factors and propel growth.

In August 2020, Aethlon Medical, a healthcare company, announced its collaboration with the University of Pittsburgh on a National Institute of Health Grant for treating head and neck cancer.

What are the Prevailing Opportunities in the Global Diagnostic Exosome Biomarkers Market?

Increasing Demand for Specialized Testing Services to Expand Market Size

The diagnostic exosome biomarkers manufacturers are outsourcing specialized testing services like Liquid Chromatography-Mass Spectrometry, RNA sequencing, wet chemistry, gene expressions, and others earlier in the API process development cycle. These services are mainly used for structural elucidation of key impurities, removing class I and II solvents, removing column chromatography, and efforts toward overall cost reduction and process efficiency.

Category- Wise Outlook

Segment	Segment Name
Product	Reagents & Kits
End User	Diagnostic Centers

Segment	Segment Share
Product	58.8%
End User	37.3%

From Convenience to Standardization: Why Reagents & Kits Dominate Exosome Biomarker Diagnostics

Reagents and kits lead the demand in the diagnostic exosome biomarkers market. The reagents are essential components used in various diagnostic procedures and research involving exosome biomarkers, making them a fundamental requirement for most applications.

The commercially available kits' convenience and time-saving aspects, including reagents and necessary protocols, attract researchers and clinicians, streamlining the experimental process. Moreover, the increasing adoption of exosome-based diagnostics in various fields, such as oncology and neurology has fueled the demand for efficient and standardized testing solutions, contributing to the popularity of reagents & kits in the market.

A Winning Strategy: Why Diagnostic Centers Lead in Exosome Biomarker Sales

Diagnostic centers lead the diagnostic exosome biomarkers sales. The diagnostic centers are dedicated facilities specializing in various diagnostic tests, including advanced biomarker assessments. Their focus on accurate and timely diagnoses attracts many patients seeking cutting-edge diagnostic services.

The diagnostic centers often collaborate with research institutions and pharmaceutical companies, surging demand for exosome biomarker testing in clinical trials and drug development studies. These centers have a broader reach, serving patients from different medical backgrounds, making them a central hub for biomarker-based testing. Also, their expertise, accessibility, and collaborative efforts contribute to their leading position in the diagnostic exosome biomarkers market.

Is Diagnostics Exosome Biomarkers Deployment Likely to be Maximum across Cancer Institutes?

Extensive Research to Develop Key Breakthroughs for Cancer Treatment Fueling Growth Prospects

According to Future Market Insights, the application of exosomes in cancer diagnosis and the development of translational precision medicine is expected to be maximum across cancer institutes. A market share worth 38.4% is anticipated for this segment in 2023.

Exosomes have proven to be highly effective in detecting multiple cancers in their early stages, with a reasonably high degree of sensitivity and specificity. Their intrinsic characteristics provide a unique ability to bypass biological impediments, notably the blood-brain barrier, or BBB. Since exosomes can target particular cell types, the transmission of therapeutic agents by exosomes could be more efficient than other vectors.

Regional Outlook

Country	Value Share in the Global Market
North America	52.6%
Europe	30.6%

How is Rising Product Launch in North America Favoring the Global Diagnostic Exosome Biomarkers Market?

North America is expected to dominate the global diagnostic exosome biomarkers industry during the forecast period. As of 2023, the region is expected to secure about 52.6% of global revenue. Domination of the region can be attributed to established players and the growing launch of products.

In April 2020, Exosome Diagnostics, a biotechnology company, launched an ExoDx Prostate test kit at home. ExoDx Prostate (EPI) test is a urine-based, genomic test that assists in detecting prostate cancer.

Such factors are expected to benefit the regional market in the forecast period.

How is the Growing Prevalence of Cancer Supporting the Market Growth of the Diagnostic Exosome Biomarkers Market?

As per the analysis, Europe is expected to be the second-leading diagnostic exosome biomarkers industry during the forecast period. In 2023, the region is likely to claim 30.6% of revenue. The development of the regional diagnostic exosome biomarkers market can be attributed to the increasing incidences of cancer across the region.

Cancer.org revealed an estimated 3.9 million new cancer cases and 1.9 million cancer deaths in Europe in 2018, which has propelled the demand for diagnostic exosome biomarkers.

Another factor contributing to the development of the regional market is the government's increasing expenditure on healthcare infrastructure.

Country	Market CAGR (From 2023 to 2033)
China	19.8%
India	16.2%
Australia	9.5%

What are the Growth Prospects for Diagnostic Exosome Biomarkers in the Asia Pacific?

Asia Pacific is projected to witness maximum growth opportunities, the study reveals. The region's expansion can be attributed to the increasing demand from developing economies like India, China, and Japan. In addition, the rising healthcare expenditures by developing countries are likely to offer remunerative opportunities for market development in the coming time.

Other factors contributing to the market growth for diagnostic exosome biomarkers include the growing prevalence of chronic disorders, increasing healthcare expenditures, and an increasing number of exosome diagnostics. Due to such factors, the diagnostic exosome biomarkers business in the Asia Pacific is likely to expand in the forecast period.

Country	Value Share in Global Market
The United States	48.3%
Germany	8.7%
Japan	4.2%

Which Marketing Tactics Can Manufacturers Utilize To Promote Diagnostic Exosome Biomarkers Market?

Collaborate with research institutions for credibility and exposure.
Host webinars and workshops to educate healthcare professionals.
Utilize social media platforms for targeted outreach and engagement.
Offer free trials and samples to encourage adoption.
Publish research papers and case studies for thought leadership.
Attend medical conferences and exhibitions to showcase products.

How are Startups Contributing to the Growth of the Diagnostic Exosome Biomarkers Industry?

Codiak Biosciences (USA), Exosome Diagnostics (US), Evox Therapeutics (US), ExoCoBio (South Korea), ILIAS Biologics (South Korea), Anjarium Biosciences (Switzerland), Xollent (US), Craif (Japan), and Carmine Therapeutics (US), are some of the emerging names in the global diagnostic exosome biomarkers market.

Update from the Industry:

In July 2017, Exosome Diagnostics Inc. announced the conclusion of its US$ 30 million Series C financing, led by insiders Tiger Partners and Forbion Capital Partners. Blue Ridge Capital, NGN Capital, Arcus Ventures, b-to-v Partners, CD Ventures, and others participated in the round, which was oversubscribed.
ExoCoBio, a South Korea-based exosome startup, raised around US$ 27 million in series B funding. The round was supported by CSQUARED Global Asset Management, Seven Tree Equity Partners, TS Investment Partners, Intervest, K2 Investment, KDB Capital, GU Equity Partners, Atinum Investment, Quantum Ventures Korea, and Platinum Technology Investment.

Competitive Landscape

Key diagnostic exosome biomarker manufacturers include AMS Biotechnology Limited, 101Bio, BioRegenerative Sciences, Inc., Cell Guidance Systems LLC, Codiak BioSciences, Evomic Science LLC, ExoCyte Therapeutics Pte Ltd, Exovita biosciences, Immune Therapy Holdings AB, Lonza Group, Norgen Biotek Corp., ReNeuron Group plc and Therapeutic Solutions International, Inc.

Novel Developments

Company	Strategy
Exo Therapeutics	Exo Therapeutics Secures US$ 78 million in Series B Financing
Bio-Techne inked	Bio-Techne and Thermo Fisher Unite for ExoTRU Kidney Transplant Rejection Test

Company	Details
Exo Therapeutics	In October 2021, Exo Therapeutics raised US$ 78 million in series B financing to develop a new strategy for drugging enzymes. Exo has developed an indirect approach to inhibit enzymes by blocking their exosites.
Bio-Techne inked	In February 2022, Bio-Techne inked an exclusive agreement with Thermo Fisher Scientific for developing and commercializing the ExoTRU kidney transplant rejection test designed by Bio-Techne. This liquid biopsy test provides allograft health information suitable for clinical and research applications.

Key Segmentation

By Product Type:

Reagents
Kits
Serum/Plasma Kits
Urine Kits
Software

By Application:

Neurodegenerative Disorders
Oncology
Metabolic Disorders
Others

By End User:

Cancer Institute
Hospital
Diagnostic Center
Others

By Region:

North America
Latin America
Europe
Asia Pacific
The Middle East and Africa

Frequently Asked Questions

What is the Projected Size of the Diagnostic Exosome Biomakers Market by 2033?

The global market size to reach US$ 888.5 million by 2033.

Top Key Players in the Diagnostic Exosome Biomakers Market?

AMS Biotechnology Limited and Lonza Group are the top key players.

What is the Growth Potential of the Diagnostic Exosome Biomakers Market?

The global market is estimated to secure a CAGR 16.3% through 2033.

What Limits the Growth Potential of the Diagnostic Exosome Biomakers Market?

The rising costs are likely to limit market growth.

Which Product Category is Highly Preferred?

The reagents & kits segment is highly preferred in the global market.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022

5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033

5.3.1. Reagents

5.3.2. Kits

5.3.3. Serum/Plasma Kits

5.3.4. Urine Kits

5.3.5. Software

5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022

5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022

6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033

6.3.1. Neurodegenerative Disorders

6.3.2. Oncology

6.3.3. Metabolic Disorders

6.3.4. Others

6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

7.1. Introduction

7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

7.3.1. North America

7.3.2. Latin America

7.3.3. Western Europe

7.3.4. Eastern Europe

7.3.5. South Asia and Pacific

7.3.6. East Asia

7.3.7. Middle East and Africa

7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

8.2.1. By Country

8.2.1.1. USA

8.2.1.2. Canada

8.2.2. By Product Type

8.2.3. By Application

8.3. Market Attractiveness Analysis

8.3.1. By Country

8.3.2. By Product Type

8.3.3. By Application

8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

9.2.1. By Country

9.2.1.1. Brazil

9.2.1.2. Mexico

9.2.1.3. Rest of Latin America

9.2.2. By Product Type

9.2.3. By Application

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Product Type

9.3.3. By Application

9.4. Key Takeaways

10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

10.2.1. By Country

10.2.1.1. Germany

10.2.1.2. UK

10.2.1.3. France

10.2.1.4. Spain

10.2.1.5. Italy

10.2.1.6. Rest of Western Europe

10.2.2. By Product Type

10.2.3. By Application

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Product Type

10.3.3. By Application

10.4. Key Takeaways

11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

11.2.1. By Country

11.2.1.1. Poland

11.2.1.2. Russia

11.2.1.3. Czech Republic

11.2.1.4. Romania

11.2.1.5. Rest of Eastern Europe

11.2.2. By Product Type

11.2.3. By Application

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Product Type

11.3.3. By Application

11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

12.2.1. By Country

12.2.1.1. India

12.2.1.2. Bangladesh

12.2.1.3. Australia

12.2.1.4. New Zealand

12.2.1.5. Rest of South Asia and Pacific

12.2.2. By Product Type

12.2.3. By Application

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Product Type

12.3.3. By Application

12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

13.2.1. By Country

13.2.1.1. China

13.2.1.2. Japan

13.2.1.3. South Korea

13.2.2. By Product Type

13.2.3. By Application

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Product Type

13.3.3. By Application

13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

14.2.1. By Country

14.2.1.1. GCC Countries

14.2.1.2. South Africa

14.2.1.3. Israel

14.2.1.4. Rest of MEA

14.2.2. By Product Type

14.2.3. By Application

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Product Type

14.3.3. By Application

14.4. Key Takeaways

15. Key Countries Market Analysis

15.1. USA

15.1.1. Pricing Analysis

15.1.2. Market Share Analysis, 2022

15.1.2.1. By Product Type

15.1.2.2. By Application

15.2. Canada

15.2.1. Pricing Analysis

15.2.2. Market Share Analysis, 2022

15.2.2.1. By Product Type

15.2.2.2. By Application

15.3. Brazil

15.3.1. Pricing Analysis

15.3.2. Market Share Analysis, 2022

15.3.2.1. By Product Type

15.3.2.2. By Application

15.4. Mexico

15.4.1. Pricing Analysis

15.4.2. Market Share Analysis, 2022

15.4.2.1. By Product Type

15.4.2.2. By Application

15.5. Germany

15.5.1. Pricing Analysis

15.5.2. Market Share Analysis, 2022

15.5.2.1. By Product Type

15.5.2.2. By Application

15.6. UK

15.6.1. Pricing Analysis

15.6.2. Market Share Analysis, 2022

15.6.2.1. By Product Type

15.6.2.2. By Application

15.7. France

15.7.1. Pricing Analysis

15.7.2. Market Share Analysis, 2022

15.7.2.1. By Product Type

15.7.2.2. By Application

15.8. Spain

15.8.1. Pricing Analysis

15.8.2. Market Share Analysis, 2022

15.8.2.1. By Product Type

15.8.2.2. By Application

15.9. Italy

15.9.1. Pricing Analysis

15.9.2. Market Share Analysis, 2022

15.9.2.1. By Product Type

15.9.2.2. By Application

15.10. Poland

15.10.1. Pricing Analysis

15.10.2. Market Share Analysis, 2022

15.10.2.1. By Product Type

15.10.2.2. By Application

15.11. Russia

15.11.1. Pricing Analysis

15.11.2. Market Share Analysis, 2022

15.11.2.1. By Product Type

15.11.2.2. By Application

15.12. Czech Republic

15.12.1. Pricing Analysis

15.12.2. Market Share Analysis, 2022

15.12.2.1. By Product Type

15.12.2.2. By Application

15.13. Romania

15.13.1. Pricing Analysis

15.13.2. Market Share Analysis, 2022

15.13.2.1. By Product Type

15.13.2.2. By Application

15.14. India

15.14.1. Pricing Analysis

15.14.2. Market Share Analysis, 2022

15.14.2.1. By Product Type

15.14.2.2. By Application

15.15. Bangladesh

15.15.1. Pricing Analysis

15.15.2. Market Share Analysis, 2022

15.15.2.1. By Product Type

15.15.2.2. By Application

15.16. Australia

15.16.1. Pricing Analysis

15.16.2. Market Share Analysis, 2022

15.16.2.1. By Product Type

15.16.2.2. By Application

15.17. New Zealand

15.17.1. Pricing Analysis

15.17.2. Market Share Analysis, 2022

15.17.2.1. By Product Type

15.17.2.2. By Application

15.18. China

15.18.1. Pricing Analysis

15.18.2. Market Share Analysis, 2022

15.18.2.1. By Product Type

15.18.2.2. By Application

15.19. Japan

15.19.1. Pricing Analysis

15.19.2. Market Share Analysis, 2022

15.19.2.1. By Product Type

15.19.2.2. By Application

15.20. South Korea

15.20.1. Pricing Analysis

15.20.2. Market Share Analysis, 2022

15.20.2.1. By Product Type

15.20.2.2. By Application

15.21. GCC Countries

15.21.1. Pricing Analysis

15.21.2. Market Share Analysis, 2022

15.21.2.1. By Product Type

15.21.2.2. By Application

15.22. South Africa

15.22.1. Pricing Analysis

15.22.2. Market Share Analysis, 2022

15.22.2.1. By Product Type

15.22.2.2. By Application

15.23. Israel

15.23.1. Pricing Analysis

15.23.2. Market Share Analysis, 2022

15.23.2.1. By Product Type

15.23.2.2. By Application

16. Market Structure Analysis

16.1. Competition Dashboard

16.2. Competition Benchmarking

16.3. Market Share Analysis of Top Players

16.3.1. By Regional

16.3.2. By Product Type

16.3.3. By Application

17. Competition Analysis

17.1. Competition Deep Dive

17.1.1. AMS Biotechnology Limited

17.1.1.1. Overview

17.1.1.2. Product Portfolio

17.1.1.3. Profitability by Market Segments

17.1.1.4. Sales Footprint

17.1.1.5. Strategy Overview

17.1.1.5.1. Marketing Strategy

17.1.2. 101Bio

17.1.2.1. Overview

17.1.2.2. Product Portfolio

17.1.2.3. Profitability by Market Segments

17.1.2.4. Sales Footprint

17.1.2.5. Strategy Overview

17.1.2.5.1. Marketing Strategy

17.1.3. BioRegenerative Sciences

17.1.3.1. Overview

17.1.3.2. Product Portfolio

17.1.3.3. Profitability by Market Segments

17.1.3.4. Sales Footprint

17.1.3.5. Strategy Overview

17.1.3.5.1. Marketing Strategy

17.1.4. Cell Guidance Systems LLC

17.1.4.1. Overview

17.1.4.2. Product Portfolio

17.1.4.3. Profitability by Market Segments

17.1.4.4. Sales Footprint

17.1.4.5. Strategy Overview

17.1.4.5.1. Marketing Strategy

17.1.5. Codiak BioSciences

17.1.5.1. Overview

17.1.5.2. Product Portfolio

17.1.5.3. Profitability by Market Segments

17.1.5.4. Sales Footprint

17.1.5.5. Strategy Overview

17.1.5.5.1. Marketing Strategy

17.1.6. Evomic Science LLC

17.1.6.1. Overview

17.1.6.2. Product Portfolio

17.1.6.3. Profitability by Market Segments

17.1.6.4. Sales Footprint

17.1.6.5. Strategy Overview

17.1.6.5.1. Marketing Strategy

17.1.7. Exovita Biosciences

17.1.7.1. Overview

17.1.7.2. Product Portfolio

17.1.7.3. Profitability by Market Segments

17.1.7.4. Sales Footprint

17.1.7.5. Strategy Overview

17.1.7.5.1. Marketing Strategy

17.1.8. Immune Therapy Holdings AB

17.1.8.1. Overview

17.1.8.2. Product Portfolio

17.1.8.3. Profitability by Market Segments

17.1.8.4. Sales Footprint

17.1.8.5. Strategy Overview

17.1.8.5.1. Marketing Strategy

17.1.9. Lonza Group

17.1.9.1. Overview

17.1.9.2. Product Portfolio

17.1.9.3. Profitability by Market Segments

17.1.9.4. Sales Footprint

17.1.9.5. Strategy Overview

17.1.9.5.1. Marketing Strategy

17.1.10. Norgen Biotek Corp.

17.1.10.1. Overview

17.1.10.2. Product Portfolio

17.1.10.3. Profitability by Market Segments

17.1.10.4. Sales Footprint

17.1.10.5. Strategy Overview

17.1.10.5.1. Marketing Strategy

17.1.11. ReNeuron Group plc

17.1.11.1. Overview

17.1.11.2. Product Portfolio

17.1.11.3. Profitability by Market Segments

17.1.11.4. Sales Footprint

17.1.11.5. Strategy Overview

17.1.11.5.1. Marketing Strategy

17.1.12. Therapeutic Solutions International, Inc.

17.1.12.1. Overview

17.1.12.2. Product Portfolio

17.1.12.3. Profitability by Market Segments

17.1.12.4. Sales Footprint

17.1.12.5. Strategy Overview

17.1.12.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 4: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 8: Latin America Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 10: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 11: Western Europe Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 12: Western Europe Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 13: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: Eastern Europe Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 15: Eastern Europe Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 16: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 17: South Asia and Pacific Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 18: South Asia and Pacific Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 19: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 20: East Asia Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 21: East Asia Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 24: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2018 to 2033

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Application, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 4: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 7: Global Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 8: Global Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 9: Global Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 10: Global Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 11: Global Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 12: Global Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 13: Global Market Attractiveness by Product Type, 2023 to 2033

Figure 14: Global Market Attractiveness by Application, 2023 to 2033

Figure 15: Global Market Attractiveness by Region, 2023 to 2033

Figure 16: North America Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 17: North America Market Value (US$ Million) by Application, 2023 to 2033

Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 19: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 22: North America Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 23: North America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 24: North America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 28: North America Market Attractiveness by Product Type, 2023 to 2033

Figure 29: North America Market Attractiveness by Application, 2023 to 2033

Figure 30: North America Market Attractiveness by Country, 2023 to 2033

Figure 31: Latin America Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 32: Latin America Market Value (US$ Million) by Application, 2023 to 2033

Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 37: Latin America Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 40: Latin America Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 41: Latin America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 43: Latin America Market Attractiveness by Product Type, 2023 to 2033

Figure 44: Latin America Market Attractiveness by Application, 2023 to 2033

Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 46: Western Europe Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 47: Western Europe Market Value (US$ Million) by Application, 2023 to 2033

Figure 48: Western Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 49: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 52: Western Europe Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 55: Western Europe Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 56: Western Europe Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 58: Western Europe Market Attractiveness by Product Type, 2023 to 2033

Figure 59: Western Europe Market Attractiveness by Application, 2023 to 2033

Figure 60: Western Europe Market Attractiveness by Country, 2023 to 2033

Figure 61: Eastern Europe Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 62: Eastern Europe Market Value (US$ Million) by Application, 2023 to 2033

Figure 63: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 64: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 67: Eastern Europe Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 70: Eastern Europe Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 73: Eastern Europe Market Attractiveness by Product Type, 2023 to 2033

Figure 74: Eastern Europe Market Attractiveness by Application, 2023 to 2033

Figure 75: Eastern Europe Market Attractiveness by Country, 2023 to 2033

Figure 76: South Asia and Pacific Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 77: South Asia and Pacific Market Value (US$ Million) by Application, 2023 to 2033

Figure 78: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033

Figure 79: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 80: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 81: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 82: South Asia and Pacific Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 83: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 84: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 85: South Asia and Pacific Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 86: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 87: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 88: South Asia and Pacific Market Attractiveness by Product Type, 2023 to 2033

Figure 89: South Asia and Pacific Market Attractiveness by Application, 2023 to 2033

Figure 90: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033

Figure 91: East Asia Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 92: East Asia Market Value (US$ Million) by Application, 2023 to 2033

Figure 93: East Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 94: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 95: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 96: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 97: East Asia Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 98: East Asia Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 99: East Asia Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 100: East Asia Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 101: East Asia Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 102: East Asia Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 103: East Asia Market Attractiveness by Product Type, 2023 to 2033

Figure 104: East Asia Market Attractiveness by Application, 2023 to 2033

Figure 105: East Asia Market Attractiveness by Country, 2023 to 2033

Figure 106: Middle East and Africa Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 107: Middle East and Africa Market Value (US$ Million) by Application, 2023 to 2033

Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033

Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 118: Middle East and Africa Market Attractiveness by Product Type, 2023 to 2033

Figure 119: Middle East and Africa Market Attractiveness by Application, 2023 to 2033

Figure 120: Middle East and Africa Market Attractiveness by Country, 2023 to 2033